Timothy Coskran
Impact in
- Pharmacology top 5%
- Cholinesterase and Neurodegenerative Diseases
- Molecular Biology top 5%
- Phosphodiesterase function and regulation
- Receptor Mechanisms and Signaling
- PI3K/AKT/mTOR signaling in cancer
- Metabolism, Diabetes, and Cancer
- Peroxisome Proliferator-Activated Receptors
Papers in
-
- Immune Cell Function and Interaction 2
- Co-authors
- Dominique BreesJohn D. McNeishKevin ColemanKristina RafidiJeffrey L. StockStephen OrenaAudrey L. HildebrandtRobert S. Garofalo
- Journals
- Journal of Clinical Investigation (2 papers)Toxicologic Pathology (2 papers)PLoS ONE (2 papers)Alzheimer s & Dementia (1 paper)Clinical Cancer Research (1 paper)
- Partner nations
- United StatesUnited KingdomCanada
In The Last Decade
Timothy Coskran
21 papers receiving 1.9k citations
Hit Papers
Peers
Comparison fields: 5 of 95
- Pharmacology 329
- Molecular Biology 1.3k
- Cellular and Molecular Neuroscience 231
- Physiology 322
- Oncology 303
Countries citing papers authored by Timothy Coskran
This map shows the geographic impact of Timothy Coskran's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Timothy Coskran with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Timothy Coskran more than expected).
Fields of papers citing papers by Timothy Coskran
This network shows the impact of papers produced by Timothy Coskran. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Timothy Coskran. The network helps show where Timothy Coskran may publish in the future.
Co-authors
The 25 scholars most cited alongside Timothy Coskran, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2024 | 1 | |
| 3 | 2022 | 1 | |
| 4 | 2021 | 2 | |
| 5 | 2020 | 4 | |
| 6 | 2019 | 35 | |
| 7 | 2017 | 4 | |
| 8 | 2017 | 2 | |
| 9 | 2016 | 47 | |
| 10 | 2015 | 29 | |
| 11 | 2014 | 9 | |
| 12 | 2014 | 3 | |
| 13 | 2013 | 7 | |
| 14 | 2009 | 33 | |
| 15 | 2009 | 7 | |
| 16 | 2006 | 204 | |
| 17 | Severe diabetes, age-dependent loss of adipose tissue, and mild growth deficiency in mice lacking Akt2/PKBβ Hit paper breakdown → | 2003 | 594 |
| 18 | 2003 | 282 | |
| 19 | 2003 | 33 | |
| 20 | 2002 | 319 |
About Timothy Coskran
Timothy Coskran is a scholar working on Immunology, Critical Care and Intensive Care Medicine, Oncology, Pharmacology and Biophysics, having authored 21 papers that have together received 1.9k indexed citations. Recurring topics across this work include Phosphodiesterase function and regulation (4 papers), Vascular Tumors and Angiosarcomas (2 papers), Virus-based gene therapy research (2 papers), Cholinesterase and Neurodegenerative Diseases (2 papers), Immune Cell Function and Interaction (2 papers), PI3K/AKT/mTOR signaling in cancer (2 papers), FOXO transcription factor regulation (2 papers) and Metabolism, Diabetes, and Cancer (2 papers). The work is most often cited by research in Pharmacology (329 citations), Molecular Biology (1.3k citations), Cellular and Molecular Neuroscience (231 citations), Physiology (322 citations) and Oncology (303 citations). Timothy Coskran has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Dominique Brees, John D. McNeish, Kevin Coleman, Kristina Rafidi, Jeffrey L. Stock, Stephen Orena, Audrey L. Hildebrandt, Robert S. Garofalo, Joan Wicks and Shawn C. Black. Their work appears in journals such as Journal of Clinical Investigation, Toxicologic Pathology, PLoS ONE, Alzheimer s & Dementia and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.